HTA4 Clinical Development and HTA Approval of MULTI-Indication Oncology Products: Evidence from Germany, France, England, Scotland, the US, Canada, and Australia

Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.034
https://www.valueinhealthjournal.com/article/S1098-3015(20)32290-7/fulltext
Title : HTA4 Clinical Development and HTA Approval of MULTI-Indication Oncology Products: Evidence from Germany, France, England, Scotland, the US, Canada, and Australia
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32290-7&doi=10.1016/j.jval.2020.08.034
First page :
Section Title :
Open access? : No
Section Order : 10022
Categories :
Tags :
Regions :
ViH Article Tags :